NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
+67.03%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$2.11B
AUM Growth
+$2.11B
Cap. Flow
+$356M
Cap. Flow %
16.84%
Top 10 Hldgs %
69.55%
Holding
49
New
3
Increased
4
Reduced
1
Closed
2
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RARX
1
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$288M 13.62% 6,138,797
ALLK
2
DELISTED
Allakos
ALLK
$216M 10.23% 2,268,188
SPT icon
3
Sprout Social
SPT
$929M
$145M 6.87% +9,046,080 New +$145M
OYST
4
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$145M 6.85% +5,925,287 New +$145M
CRSP icon
5
CRISPR Therapeutics
CRSP
$4.71B
$127M 6.02% 2,090,678
ARDX icon
6
Ardelyx
ARDX
$1.53B
$121M 5.72% 16,135,047 +800,000 +5% +$6M
RYTM icon
7
Rhythm Pharmaceuticals
RYTM
$6.85B
$113M 5.33% 4,912,306
EPZM
8
DELISTED
Epizyme, Inc
EPZM
$108M 5.09% 4,377,518
AUPH icon
9
Aurinia Pharmaceuticals
AUPH
$1.58B
$105M 4.96% 5,172,683
MIRM icon
10
Mirum Pharmaceuticals
MIRM
$3.71B
$103M 4.86% 4,187,801
NET icon
11
Cloudflare
NET
$72.7B
$71.2M 3.37% 4,059,376
MRSN icon
12
Mersana Therapeutics
MRSN
$36.5M
$68.6M 3.24% 11,963,649
GRTX
13
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$57.4M 2.72% +4,362,986 New +$57.4M
DERM
14
DELISTED
Dermira, Inc.
DERM
$53.2M 2.51% 3,506,649
CBIO
15
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
$48.1M 2.27% 9,089,041
PHAS
16
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$40.6M 1.92% 6,643,704
SENS icon
17
Senseonics Holdings
SENS
$374M
$28.4M 1.34% 30,888,266
MEIP icon
18
MEI Pharma
MEIP
$160M
$21.2M 1% 8,533,072 +2,812,500 +49% +$6.97M
ADAP
19
Adaptimmune Therapeutics
ADAP
$15.6M
$19M 0.9% 15,832,611
OBSV
20
DELISTED
ObsEva SA Ordinary Shares
OBSV
$17.5M 0.83% 4,586,563
AFMD
21
DELISTED
Affimed
AFMD
$16.8M 0.79% 6,126,488 +987,600 +19% +$2.71M
TRVI icon
22
Trevi Therapeutics
TRVI
$883M
$16.7M 0.79% 4,441,360
AVEO
23
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$15.8M 0.75% 25,243,865
GNCA
24
DELISTED
Genocea Biosciences, Inc.
GNCA
$15M 0.71% 7,225,676
MRKR icon
25
Marker Therapeutics
MRKR
$12M
$14.4M 0.68% 5,000,000